NDC 75987-0130-15
Tepezza (Teprotumumab)
Package · 1 VIAL, SINGLE-DOSE in 1 CARTON (75987-130-15) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
500 mg/1 · Lyophilized Injection Powder
By Horizon Therapeutics USA, Inc.
Teprotumumab · Lyophilized Powder for Injection · 500 mg · IV
- NDC
- 75987-0130-15
- Route
- Intravenous
- Therapeutic class
- Insulin-like Growth Factor-1 Receptor Inhibitor , Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]
- Marketing category
- BLA
Request This Medication
*Expect a reply within 2 business hours with availability and pricing.
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request a Quote
Request this medication.
Tell us the quantity you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.
- DSCSA-compliant pedigree on every order
- Cold-chain capable where applicable
- Same-day fulfillment available for urgent needs
Related in Diabetes & Endocrine
See all →
Omeosport
Pellet
NDC 17089-0075-20
2 TUBE in 1 BOX (17089-075-20) / 4 g in 1 TUBE
Available to Source
Guna-Geriatrics
Solution / Drops
NDC 17089-0349-18
1 BOTTLE, DROPPER in 1 BOX (17089-349-18) / 30 mL in 1 BOTTLE, DROPPER
Available to Source
Procort (1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream)
18.5 mg/g / 11.5 mg/g · Cream
NDC 50967-0357
Available to Source
1% Hydrocortisone
10 mg/g · Cream
NDC 79903-0211-01
1 TUBE in 1 CARTON (79903-211-01) / 28 g in 1 TUBE
Available to Source